机构：[1]Department of Neurology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310000, China.[2]Department of Neurology, The Second Affiliated Hospital, School of Medicine, Zhejiang University, Hangzhou 310000, China.[3]Department of Neurology, The Third People's Hospital of Henan Province, Zhengzhou 450000, China.[4]Laboratory of iPSC and Disease Models, Cell Inspire Biotechnology Co., Ltd, Shenzhen 518101, China.[5]Department of Clinical Pharmacy, The First Affiliated Hospital, Zhejiang University School of Medicine, Hangzhou 310000, China.浙江大学医学院附属第一医院[6]Division of Neurology, Department of Medicine, University of Hong Kong, Hong Kong.[7]The 1st School of Medicine, School of Information and Engineering, Wenzhou Medical University, Wenzhou 325000, Zhejiang, China.[8]Department of Anesthesiology and Pain, The Affiliated Hospital of Jiaxing University, Jiaxing 314000, Zhejiang, China.[9]Department of Neurology, First Affiliated Hospital of Kunming Medical University, No.1 School of Clinical Medicine, Kunming Medical University, Kunming 650500, China.内科科室神经内科昆明医科大学附属第一医院[10]School of Rehabilitation, Kunming Medical University, Kunming 650500, China.
Kunming Medical University Grant numbers: National Natural
Science Foundation of China/NO. 82060421, Basic Research Program of
Yunnan Science and Technology Department/No. 202101AT070255;
The First Affiliated Hospital of Kunming Medical University Grant
numbers: National Natural Science Foundation of China/No. 82160233,
Yunnan Basic Research Research Funding/202201AY070001-071,
Yunnan Health Training Project of High Level Talents/H-2017032,
Technology Special Project of Yunnan Province/202102AA100061;
Affiliated Hangzhou First People’s Hospital, Zhejiang University of
School of Medicine Grant numbers: Hangzhou Health Science and
Technology Plan, 2018A19.
第一作者机构：[1]Department of Neurology, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310000, China.
共同第一作者：
通讯作者：
推荐引用方式(GB/T 7714)：
Li Lingfei,Si Xiaoli,Lei Meng,et al.Generation of a human iPSC line (CIBi013-A) from a patient with young-onset Parkinson's disease carrying a novel homozygous PARK7 (DJ-1) mutation[J].STEM CELL RESEARCH.2023,66:102983.doi:10.1016/j.scr.2022.102983.
APA：
Li Lingfei,Si Xiaoli,Lei Meng,Yang Jiayin,Ruan Jie...&Liu Yao.(2023).Generation of a human iPSC line (CIBi013-A) from a patient with young-onset Parkinson's disease carrying a novel homozygous PARK7 (DJ-1) mutation.STEM CELL RESEARCH,66,
MLA：
Li Lingfei,et al."Generation of a human iPSC line (CIBi013-A) from a patient with young-onset Parkinson's disease carrying a novel homozygous PARK7 (DJ-1) mutation".STEM CELL RESEARCH 66.(2023):102983
